Matthew Simonian

Matthew Simonian is a biopharmaceutical strategist and leader currently heading Strategic Operations for Global Epilepsy and Rare Syndromes at UCB. They have held various roles in epilepsy marketing, including Senior Director at Cyberonics and Associate Director at UCB Pharma, where they contributed to the evolution of epilepsy portfolios. With over 20 years of experience in the healthcare industry, they have also served as an independent consultant specializing in global marketing and strategy for pharmaceuticals and medical devices. Matthew earned a Master’s in Biology with an emphasis in Anatomy and Physiology and a Bachelor of Arts in Functional Biology from California State University-Fresno.